MAPT and Alzheimer disease: The co-occurrence network (Figure 7A) highlighted prominent topics such as AD, mild cognitive impairment (MCI), dementia, amyloid beta (Aβ), cerebrospinal fluid (CSF), tau, and the National Institute.